These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
181 related items for PubMed ID: 19709134
1. Chronic antiepileptic monotherapy, bone metabolism, and body composition in non-institutionalized children. Rauchenzauner M, Griesmacher A, Tatarczyk T, Haberlandt E, Strasak A, Zimmerhackl LB, Falkensammer G, Luef G, Högler W. Dev Med Child Neurol; 2010 Mar; 52(3):283-8. PubMed ID: 19709134 [Abstract] [Full Text] [Related]
2. Effect of valproic acid treatment on body composition, leptin and the soluble leptin receptor in epileptic children. Rauchenzauner M, Haberlandt E, Scholl-Bürgi S, Karall D, Schoenherr E, Tatarczyk T, Engl J, Laimer M, Luef G, Ebenbichler CF. Epilepsy Res; 2008 Aug; 80(2-3):142-9. PubMed ID: 18472247 [Abstract] [Full Text] [Related]
3. Evaluation of bone mineral density in children receiving carbamazepine or valproate monotherapy. Chou IJ, Lin KL, Wang HS, Wang CJ. Acta Paediatr Taiwan; 2007 Aug; 48(6):317-22. PubMed ID: 18437965 [Abstract] [Full Text] [Related]
4. Efficacy and tolerability of conversion to monotherapy with lamotrigine compared with valproate and carbamazepine in patients with epilepsy. Fakhoury TA, Hammer AE, Vuong A, Messenheimer JA. Epilepsy Behav; 2004 Aug; 5(4):532-8. PubMed ID: 15256191 [Abstract] [Full Text] [Related]
6. A 6-month longitudinal study of bone mineral density with antiepileptic drug monotherapy. Kim SH, Lee JW, Choi KG, Chung HW, Lee HW. Epilepsy Behav; 2007 Mar; 10(2):291-5. PubMed ID: 17224308 [Abstract] [Full Text] [Related]
9. Potential effects of valproate and oxcarbazepine on growth velocity and bone metabolism in epileptic children- a medical center experience. Lin CM, Fan HC, Chao TY, Chu DM, Lai CC, Wang CC, Chen SJ. BMC Pediatr; 2016 May 03; 16():61. PubMed ID: 27142370 [Abstract] [Full Text] [Related]
10. Fish liver oil and propolis as protective natural products against the effect of the anti-epileptic drug valproate on immunological markers of bone formation in rats. Elwakkad AS, El Elshamy KA, Sibaii H. Epilepsy Res; 2008 Jul 03; 80(1):47-56. PubMed ID: 18455911 [Abstract] [Full Text] [Related]
12. Vitamin D levels and bone turnover in epilepsy patients taking carbamazepine or oxcarbazepine. Mintzer S, Boppana P, Toguri J, DeSantis A. Epilepsia; 2006 Mar 03; 47(3):510-5. PubMed ID: 16529614 [Abstract] [Full Text] [Related]
13. Early detection of bone metabolism changes under different antiepileptic drugs (ED-BoM-AED)--a prospective multicenter study. Bauer S, Hofbauer LC, Rauner M, Strzelczyk A, Kellinghaus C, Hallmeyer-Elgner S, Oertel WH, Rosenow F. Epilepsy Res; 2013 Oct 03; 106(3):417-22. PubMed ID: 23916144 [Abstract] [Full Text] [Related]
14. Metabolic and hormonal disturbances in women with epilepsy on antiepileptic drug monotherapy. Kim JY, Lee HW. Epilepsia; 2007 Jul 03; 48(7):1366-70. PubMed ID: 17565596 [Abstract] [Full Text] [Related]
17. Bone health in young women with epilepsy after one year of antiepileptic drug monotherapy. Pack AM, Morrell MJ, Randall A, McMahon DJ, Shane E. Neurology; 2008 Apr 29; 70(18):1586-93. PubMed ID: 18443309 [Abstract] [Full Text] [Related]
20. Antiepileptic drugs and bone metabolism in children: data from 128 patients. Borusiak P, Langer T, Heruth M, Karenfort M, Bettendorf U, Jenke AC. J Child Neurol; 2013 Feb 29; 28(2):176-83. PubMed ID: 22550090 [Abstract] [Full Text] [Related] Page: [Next] [New Search]